Literature DB >> 12108955

Nonviral gene therapy.

S Li1, Z Ma.   

Abstract

The last 10 years have seen substantial progress in the development and application of nonviral vectors in gene therapy. Several novel nonviral methods have been developed that approach viruses with respect to transfection efficiency. A variety of nonviral delivery systems that can be used for gene therapy in different clinical settings are also available. In this review article, we will detail all of the major nonviral vectors that are currently used in gene therapy while highlighting some recent developments, particularly the progress towards the understanding of the cellular and in vivo barriers in gene transfer. Recent advancement in achieving sustained and regulated gene expression will also be addressed. Finally, this review will briefly cover targeted gene repair using nonviral delivery systems. Their impact in gene therapy will also be discussed.

Mesh:

Substances:

Year:  2001        PMID: 12108955     DOI: 10.2174/1566523013348814

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  14 in total

1.  Oncolytic Activity of Targeted Picornaviruses Formulated as Synthetic Infectious RNA.

Authors:  Noura B Elsedawy; Rebecca A Nace; Stephen J Russell; Autumn J Schulze
Journal:  Mol Ther Oncolytics       Date:  2020-05-19       Impact factor: 7.200

Review 2.  Targeted gene insertion for molecular medicine.

Authors:  Katrin Voigt; Zsuzsanna Izsvák; Zoltán Ivics
Journal:  J Mol Med (Berl)       Date:  2008-07-08       Impact factor: 4.599

Review 3.  Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.

Authors:  Ramalinga Kuruba; Annette Wilson; Xiang Gao; Song Li
Journal:  AAPS J       Date:  2009-01-09       Impact factor: 4.009

Review 4.  Gene therapy: regulations, ethics and its practicalities in liver disease.

Authors:  Xi Jin; Yi-Da Yang; You-Ming Li
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

5.  Myeloma xenograft destruction by a nonviral vector delivering oncolytic infectious nucleic acid.

Authors:  Elizabeth M Hadac; Elizabeth J Kelly; Stephen J Russell
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

6.  Targeted nanoparticles enhanced flow electroporation of antisense oligonucleotides in leukemia cells.

Authors:  Shengnian Wang; Xulang Zhang; Bo Yu; Robert J Lee; L James Lee
Journal:  Biosens Bioelectron       Date:  2010-07-01       Impact factor: 10.618

7.  Gold nanoparticles enhanced electroporation for mammalian cell transfection.

Authors:  Yingbo Zu; Shuyan Huang; Wei-Ching Liao; Yang Lu; Shengnian Wang
Journal:  J Biomed Nanotechnol       Date:  2014-06       Impact factor: 4.099

8.  Electric field-mediated transport of plasmid DNA in tumor interstitium in vivo.

Authors:  Joshua W Henshaw; David A Zaharoff; Brian J Mossop; Fan Yuan
Journal:  Bioelectrochemistry       Date:  2007-08-01       Impact factor: 5.373

9.  Relaxin treatment of solid tumors: effects on electric field-mediated gene delivery.

Authors:  Joshua Henshaw; Brian Mossop; Fan Yuan
Journal:  Mol Cancer Ther       Date:  2008-08       Impact factor: 6.261

10.  Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor.

Authors:  Shu-Hao Hsu; Bo Yu; Xinmei Wang; Yuanzhi Lu; Carl R Schmidt; Robert J Lee; L James Lee; Samson T Jacob; Kalpana Ghoshal
Journal:  Nanomedicine       Date:  2013-05-30       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.